Accueil » Tag archives : Featured (page 3)

Tag archives : Featured

COVID-19: TIF Releases Position Statement on the Inclusion of Thalassaemia & SCD Patients in the High-Risk Population

  The SARS-CoV-2 infection presents particular challenges and great risks to patients with thalassaemia and sickle cell disease (SCD) and, if their appropriate clinical management as described in International Guidelines is not safeguarded in the context of national policies developed for fighting COVID-19, their health and quality of life will ...

Lire la suite...

JUST LANDED: A new TIF Publication on Blood & COVID-19

Is the new coronavirus transfusion transmittable? What is the guidance that internationally acclaimed bodies, such as the World Health Organisation (WHO), the US Centers for Disease Control and Prevention (CDC) and others provide with regard to adequacy and safety of blood and its products? This brand new informational guide about ...

Lire la suite...

Novavax to start human trial for ‘ideal’ coronavirus vaccine candidate

The biotech company Novavax announced today that it has identified an “ideal” coronavirus vaccine candidate — and is set to launch the first clinical human trial in mid-May. The candidate, NVX-CoV2373, proved its ability to produce immune responses and high levels of antibodies against COVID-19 in pre-clinical animal trials, the Gaithersburg, ...

Lire la suite...

IMPORTANT ANNOUNCEMENT: TIF reschedules the International Thalassaemia Day 2020 Celebrations for the 8th of September due to coronavirus

  Given the unprecedented global public health crisis brought on by the COVID-19 pandemic, TIF announces that the celebrations of the International Thalassaemia Day 2020 on the 8th of May, including all the Federation’s activities that were initially programmed, are rescheduled for Monday, 8 September 2020. TIF strongly urges its members ...

Lire la suite...

TIF publishes new material on the COVID-10 Pandemic

TIF continues the efforts to address the questions and concerns of its global patients’ and healthcare professionals’ community about the COVID-19 Pandemic and, in doing so, it has issued 2 brand new informational documents. The TIF-proposed Haemoglobinopathy Patient Pathway for Day Care Centres, Units and Clinics treating patients with thalassaemia ...

Lire la suite...